Prescription drug market sales share of LLPs Japan 2008-2019
In 2019, long-listed products (LLPs) accounted for about 15.5 percent of the Japanese prescription drug market, down from 35.9 percent in 2009. That year, the drug market share of generics in Japan reached about 15.6 percent.